US health officials are reportedly reexamining a $590 million agreement awarded to Moderna (Nasdaq: MRNA) for the development ...

Kallyope’s latest obesity drug trial results show modest weight-loss effects that lag behind competing therapies in the ...

Neurocrine Biosciences (Nasdaq: NBIX) has announced positive results from its Phase IV KINECT-PRO study, showing that ...

Israeli drug manufacturer Teva Pharmaceutical Industries has resumed the deliveries of the scarce epilepsy drug Finlepsin ...

A pair of Republicans have reintroduced the bicameral Reciprocity Ensures Streamlined Use of Lifesaving Treatments (RESULT) ...

Berlin, Germany-based radioisotopes specialist Eckert & Ziegler today announced a comprehensive strategic partnership with ...

Privately-held French drugmaker Servier has announced the appointment of Nitza Thomasson as executive director, R&D Neurology ...

The government of Ukraine plans to increase public procurements of drugs this year and to make them more affordable for local ...

The Californian company earlier announced the US Food and Drug Administration’s (FDA) acceptance of a supplemental New Drug ...

Johnson & Johnson (NYSE: JNJ) has taken legal action against Samsung Bioepis, accusing the South Korean biotech of violating ...

A group representing compounding pharmacies has filed a lawsuit against the US Food and Drug Administration, arguing that the ...

UCB exceeded market expectations in the fourth quarter of 2024, reporting revenue of 1.89 billion euros ($2.05 billion), an 8 ...